HOUSTON, TX — October 10, 2025 — Leads & Copy — Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) will participate in the 2025 Maxim Growth Summit on October 22nd at The Hard Rock Hotel NYC. The event brings together industry experts, innovators, and thought leaders to explore the latest trends and advancements across several industries.
Attendees can engage with Nexalin’s management and learn about its proprietary, non-invasive neurostimulation which is a drug-free, clinically proven treatment with the potential to scale worldwide.
Nexalin designs and develops neurostimulation products to combat the global mental health epidemic. Its products are non-invasive and undetectable and provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues, and its neurostimulation medical devices can penetrate structures deep in the mid-brain. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman.
Contact: Crescendo Communications, LLC, Tel: (212) 671-1020, Email: NXL@crescendo-ir.com
Source: Nexalin Technology, Inc.
